Literature DB >> 15015980

Use of recombinant factor VIIa in inherited platelet disorders.

Mohamed Kaleelrahman, Adrian Minford, Liakat Ali Parapia.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15015980     DOI： 10.1111/j.1365-2141.2004.04878.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  4 in total

1.  Innovative use of recombinant activated factor VII during physical rehabilitation in an Italian child with Glanzmann's thromboasthenia.

Authors:  Paola Giordano; Giuseppe Lassandro; Riccardina Tesse; Stefania Longo; Federica Valente; Anna Rita Cappiello; Antonio Coppola
Journal:  Blood Transfus       Date:  2012-07-04       Impact factor: 3.443

Review 2.  The bleeding child. Part I: primary hemostatic disorders.

Authors:  C Heleen van Ommen; Marjolein Peters
Journal:  Eur J Pediatr       Date:  2011-07-29       Impact factor: 3.183

3.  Menstrual and obstetrical bleeding in women with inherited platelet receptor defects-A systematic review.

Authors:  Marieke C Punt; Pauline C E Schuitema; Kitty W M Bloemenkamp; Idske C L Kremer Hovinga; Karin P M van Galen
Journal:  Haemophilia       Date:  2020-01-31       Impact factor: 4.287

Review 4.  Clinical use of recombinant human activated factor VII (rFVIIa) in the prevention and treatment of bleeding episodes in patients with Glanzmann's thrombasthenia.

Authors:  Man-Chiu Poon
Journal:  Vasc Health Risk Manag       Date:  2007
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.